Editorially independent · We do not sell peptides

GHRP-6

Synthetic hexapeptide ghrelin-receptor agonist · GH release + appetite stimulation

EVIDENCE GRADE
C
Limited
TYPE
Hormonal
EU
NOT AUTHORISED
US
NOT AUTHORISED
MOLECULAR INFORMATION

Molecular information

Length
9 amino acids
Type
Synthetic hexapeptide ghrelin-receptor agonist · GH release + appetite stimulation
Amino acid sequence
His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂

GHRP-6 is a synthetic hexapeptide GH secretagogue, an early-generation ghrelin-receptor agonist. Marketed grey-market alongside GHRP-2 and ipamorelin in stacking protocols. Documented pharmacology includes a marked hunger response — typically positioned as a feature, sometimes as a deal-breaker.

Claims vs evidence

  • GH / IGF-1 elevation — pharmacology supports a transient peak; chronic efficacy unstudied
  • Lean-mass gain — small, short-duration trials only
  • Wound healing — preclinical only

Why we grade it C

Real GH-secretagogue activity backed by pharmacological studies in humans, but no completed Phase 3 in any therapeutic indication. The grey-market supply chain is not authorised in the EU. Less attractive than GHRP-2 in diagnostic-use markets because of the hunger profile.

Related compounds

Other compounds in this category